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Abstract 
Inflammatory mediators induce neuropeptide release from nociceptive nerve endings 
and cell bodies, causing increased local blood flow and vascular leakage resulting in 
edema. Neuropeptide release from sensory neurons depends on an increase in 
intracellular Ca2+ concentration. In this study we investigated the role of two types of pH 
sensors in acid-induced Ca2+ entry and neuropeptide release from dorsal root ganglion 
(DRG) neurons. The transient receptor potential vanilloid 1 channel (TRPV1) and acid-
sensing ion channels (ASICs) are both H+-activated ion channels present in these 
neurons, and are therefore potential pH sensors for this process. We demonstrate with 
in situ hybridization and immunocytochemistry that TRPV1 and several ASIC subunits 
are co-expressed with neuropeptides in DRG neurons. Activation of ASICs and of 
TRPV1 led to an increase in intracellular Ca2+ concentration.  While TRPV1 has a high 
Ca2+ permeability and allows direct Ca2+ entry when activated, we show here that ASICs 
of DRG neurons mediate Ca2+ entry mostly by depolarization-induced activation of 
voltage-gated Ca2+ channels and only to a small extent via the pore of Ca2+-permeable 
ASICs. Extracellular acidification led to release of the neuropeptide calcitonin gene-
related peptide from DRG neurons. The pH dependence and the pharmacological 
profile indicated that TRPV1, but not ASICs, induced neuropeptide secretion. In 
conclusion, this study shows that although both TRPV1 and ASICs mediate Ca2+ influx, 
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Introduction 
Dorsal root ganglion (DRG) neurons transmit sensory information from the periphery to the 
CNS. The size of DRG neurons correlates with their function; small-diameter neurons 
transmit nociceptive information whereas large-diameter neurons are closely related to the 
transmission of proprioceptive and tactile signals (Harper and Lawson, 1985; Nakamura and 
Strittmatter, 1996). In addition to their sensory roles, DRG neurons have efferent functions 
and can release neuropeptides such as substance P (SP) and calcitonin gene-related peptide 
(CGRP), which regulate inflammatory processes and the blood flow in the microcirculation 
and can induce and maintain neurogenic inflammation (Steinhoff et al., 2003). Neuropeptide 
secretion has been observed from peripheral termini and from cell bodies of sensory neurons 
(Huang and Neher, 1996). The role of neuropeptide secretion from cell bodies is not well 
understood and may have roles in the modulation of neuronal excitability and provide 
autocrine and paracrine functions. Since the DRG somata express many of the channels and 
receptors present in the nerve termini, they are widely used as a sensory neuron model system. 
Neuropeptide secretion is generally induced by a membrane depolarization and an increase in 
intracellular Ca2+ concentration (Huang and Neher, 1996). A small percentage of vesicle 
release from DRG somata is Ca2+-independent (Zhang and Zhou, 2002).   
Inflammation and ischemia are accompanied by a tissue acidification that activates mainly 
two types of pH-sensing ion channels in DRG neurons, the transient receptor potential 
vanilloid 1 (TRPV1) channel and acid-sensing ion channels (ASICs). Activation of these 
channels may lead to Ca2+ entry into the neuron and to neuropeptide secretion. TRPV1 and 
ASICs have distinct properties and may differently contribute to this process. TRPV1 is 
activated by noxious warm temperature (>43°C), acidic pH and capsaicin (Caterina et al., 
1997; Tominaga et al., 1998). This channel is permeable to Ca2+ and Na+.  ASICs are homo- 
or heterotrimeric H+-activated Na+ channels (Jasti et al., 2007) that are widely expressed in 
the central and the peripheral nervous system (Waldmann et al., 1997).  Four ASIC genes are 
known and several of them exist in different splice variants (Wemmie et al., 2006; Wemmie et 
al., 2013). Among the different ASIC types, only ASIC1a homotrimers and ASIC1a/2b 
heterotrimers are in addition to Na+ also permeable to Ca2+ (Bassler et al., 2001; Sherwood et 
al., 2011; Sutherland et al., 2001; Waldmann et al., 1997).  In contrast to TRPV1 which 
produces sustained currents when the extracellular pH is lowered, ASICs are only transiently 
activated and desensitize within seconds. The pH required to activate 50% of the channels is 
in the range of 6 - 6.5 for many ASIC subtypes and ~5 for TRPV1, indicating that TRPV1 
requires more acidic conditions for activation than most ASICs (Caterina et al., 1997; 
Waldmann et al., 1997). There is evidence from studies with knockout mice and 
pharmacological approaches that both, TRPV1 and ASICs are involved in different forms of 
inflammation-related pain sensation (Caterina et al., 2000; Patapoutian et al., 2009; Price et 
al., 2001; Sluka et al., 2009). Since the activation of TRPV1 or ASICs likely increases 
intracellular Ca2+ concentrations either by direct Ca2+ entry across these channels or by 
depolarization-induced activation of voltage-gated Ca2+ channels (Cavs), their activation may 
induce neuropeptide release. Several studies have already demonstrated such a role of TRPV1 
in sensory neurons, heart and trachea (Fischer et al., 2003; Kichko and Reeh, 2009; Strecker 
et al., 2005). It was shown that ASIC3 is not involved in CGRP release from heart or stomach 
(Auer et al., 2010; Strecker et al., 2005), but a role of other ASIC isoforms in neuropeptide 
release has not been investigated.  Previous observations suggested the existence of DRG 
neuron subpopulations expressing exclusively Ca2+-permeable ASICs (Poirot et al., 2006). To 
test whether in these neurons ASICs contribute to neuropeptide release we have first analyzed 
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in DRG neurons the co-expression of ASIC subunits with the neuropeptides CGRP and SP by 
using immunocytochemistry and in situ hybridization. We measured then the Ca2+ entry into 
DRG neurons due to activation of ASICs and TRPV1 and determined finally the CGRP 
secretion from DRG neurons after an extracellular acidification. We show that activation of 
both channel types promotes Ca2+ entry and that only TRPV1, but not ASIC activation 
induces CGRP secretion.  
 
Material and methods 
DRG neuron isolation and culture 
All experimental procedures on rats were carried out in accordance with the Swiss federal law 
on animal welfare and had been approved by the committee on animal experimentation of the 
Canton de Vaud. Rats were killed using CO2. DRG neurons were prepared as described 
previously (Poirot et al., 2006). Lumbar DRGs (L1–L6) were removed bilaterally and 
collected in PBS (in mM, 137 NaCl, 2.7 KCl, 10 Na2HPO4, 2 KH2PO4, pH 7.4) containing 50 
U ml−1 penicillin and 50 µg ml−1 streptomycin (Invitrogen, Basel, Switzerland). DRGs were 
then incubated for 2 hours at 37°C in Neurobasal A medium (Invitrogen) complemented with 
10% heat-inactivated fetal calf serum (FCS, Invitrogen), 22 mM glucose, and sucrose to 
adjust the osmolarity to 320 mosmol l−1 (named here NeuroA medium), containing 0.125% 
collagenase type P (Roche, Basel, Switzerland). DRGs were then washed twice with PBS, 
treated with 0.25% trypsin (Invitrogen) in PBS for 30 min at 37°C, washed with NeuroA and 
taken up in NeuroA complemented with 50 µg ml−1 DNase and soybean trypsin inhibitor 
(Sigma, Buchs, Switzerland). The ganglia were triturated 4–6 times with a fire-polished 
Pasteur pipette or a blue micropipette tip to obtain a cell suspension. DRG neurons were 
plated either on glass coverslips, or in 24-well plates that had previously been coated with a 
high molecular weight (>300’000 Da) poly-l-lysine (Sigma) solution (0.2 mg ml−1). The 
neurons were maintained in NeuroA at 37°C, 5% CO2 and 90% humidity for 3 h. Afterwards, 
neurons were maintained at 4°C in Leibovitz's L15 medium supplemented with 10% FCS and 
5 mM Hepes, pH 7.4, 320 mosmol l−1 to prevent changes in protein expression (Blair and 
Bean, 2002). 
Immunocytochemistry 
Cells on coverslips were washed three times with PBS and fixed with freshly prepared 4% 
paraformaldehyde in PBS for 20 min, washed three times in PBS containing 0.5% BSA 
(protease free, Acros Organics) and permeabilized with 0.4% Triton X-100 (Sigma) in PBS 
for 10 min. Subsequently, cells were incubated with the first antibody or antibodies (for co-
labeling by antibodies of different species) in PBS containing 2% BSA and 0.1% Triton X-
100, for two hours at RT. Cells were washed three times in PBS / 0.5% BSA and incubated 
with secondary antibodies in PBS / 2% BSA / 0.1% Triton X-100 for one hour at RT. Cells 
were washed three times in PBS / 0.5% BSA. The coverslips were mounted on a glass 
microscope slide with Vectashield medium (Reactolab, Servion, Switzerland).  
The following antibodies were used for immunocytochemistry: NeuN, primary monoclonal 
mouse antibody (1:500, Merck Millipore, Darmstadt, Germany), secondary antibody coupled 
with CY5 (1:200, Jackson ImmunoResearch Europe, Suffolk, UK); Neuropeptides, rabbit 
antibody (SP, 1:1000, BD Biosciences, Allschwil, Switzerland) and (CGRP, 1:1000, Bachem, 
Bubendorf, Switzerland), secondary antibody coupled to CY3 (1:200, Jackson 
ImmunoResearch); ion channels, rabbit antibody against ASIC1 (1:500, MTY19 (Wemmie et 
al., 2003)) rabbit antibody against ASIC2 (1:200, ASIC2 (Gannon et al., 2008)) rabbit 
antibody against TRPV1 (1:2000, Santa Cruz Biotechnology, Heidelberg, Germany), 
secondary antibody coupled to FITC (1:200, Jackson ImmunoResearch).  None of the 
commercially available ASIC3 antibodies produced specific staining in our hands. For some 
experiments two primary antibodies raised in rabbit were used. In these cases, the protocol 
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was modified in the following way. During the first antibody incubation step, one rabbit 
antibody was used. This was followed by a 1-hour incubation with a Fab fragment secondary 
antibody against the first primary antibody (1:200, Jackson ImmunoResearch) to block the 
epitopes of the primary antibody to avoid any interference with the secondary antibody of the 
second step (Negoescu et al., 1994). An additional incubation with unconjugated Fab 
fragments was used to block all the epitopes of the first antibody of the first step (2 hours, 
1:100, Jackson ImmunoResearch) (Dou et al., 2004). A second cycle of primary and 
secondary antibody incubation was then performed, using the second primary and secondary 
antibodies.  
 
In situ hybridization 
Oligonucleotides were labelled with digoxigenin (DIG)-ddUTP with the DIG Oligonucleotide 
3’-End Labelling Kit (Roche), following the manufacturer’s protocol. The sequences of the 
anti-sense probes used are indicated in Suppl. Table 1. Sense oligonucleotides were used as 
negative controls.  The protocol of (Kokaia, 2001) was followed for in situ hybridization. 
Cells were rinsed twice in PBS, fixed for 10 min in 4% paraformaldehyde at RT, rinsed twice 
in PBS and permeabilized for 5 min in PBS / 0.1% Triton X-100 / 5% vanadyl ribonucleoside 
complex (New England Biolabs, Ipswich, USA). The DIG-labeled probes were applied at a 
concentration of 5 nM in hybridization buffer (50% (v/v) deionized formamide (Sigma), 4× 
SSC, 1× Denhardt solution, 1% N-laurylsarcosine (Sigma), 20 mM phosphate pH 7.0, 0.55 
mg/ml salmon testes DNA (Sigma), 100 g/l dextran sulphate (Sigma)) and the cover slips 
were incubated in a humidified chamber at 37°C for 16 to 18 hours. The coverslips were 
rinsed once with SSC (150 mM NaCl, 15 mM sodium citrate, pH 7.0) at 48°C and incubated 
three times for 30 min each in SSC at 48°C and then allowed to cool down to RT in 1xSSC. 
The coverslips were washed twice in binding buffer (150 mM NaCl, 100 mM Tris, pH 7.5) 
and were incubated for 3 h in a humidified chamber at RT in binding buffer with anti-DIG-
fluorescein-conjugated antibody (1:10, Roche), 1% normal sheep serum (Invitrogen) and 
0.3% Triton X-100 (Sigma). The coverslips were then washed 4 times in binding buffer, twice 
in wash buffer (100 mM NaCl, 100 mM Tris, 50 mM MgCl2, pH 9.5), and twice in water. 
 
Microscopy and cell counting 
In situ hybridization and immunocytochemistry slides were examined using a confocal 
microscope (LSM 710, Carl Zeiss, Feldbach, Switzerland) with an EC Plan-Neofluar 40x/1.30 
Oil DIC M27 objective and analyzed with ImageJ. The neurons were labeled with an antibody 
against NeuN to determine the regions of interest (ROI). Each fluorescent region delimited a 
neuron. The average grey scale value for each other fluorescent dye was then measured in 
each ROI. For each type of antibody or oligonucleotide, the signal intensity clearly 
distinguished two sub-populations, corresponding to labeled and non-labeled neurons. A 
threshold value was chosen that separated optimally the negative from the positive population, 
and neurons whose signal intensity was above the threshold were counted as positive. The 
diameter of the neurons was calculated from the area of each ROI. 
 
Calcium imaging 
Coated cover slips containing the cells were mounted in the perfusion chamber (Warner 
Instruments, Hamden, USA) and incubated with 5 µM Fura2-AM in Tyrode solution (in mM, 
140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 MES, 10 Hepes, 10 glucose) at pH 7.4 for 30 min 
(CHO cells) or 20 min (neurons) in the dark at 37°C. Experiments were carried out with an 
inverted microscope (Zeiss Axio Observer). Solutions were changed with the cFlow flux 
controller (Cell MicroControls, Norfolk, USA) and the Solution Changer Manifold MSC-200 
(Bio-Logic, Claix, France) and images were recorded  (excitation: 340, 380 nm, emission 520 
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nm) with a CoolSnap HQ camera (Photometrics, Tucson, USA), using the Metafluor software 
(Molecular Devices, Sunnyvale, USA). The Na+-free Tyrode solution contained, in mM, 170 
N-methylglucosamine, 4 KCl, 2 CaCl2, 1 MgCl2, 10 MES, 10 HEPES, 10 Glucose, 30 
sucrose. For the analysis, the baseline value was subtracted from the peak fluorescence signal.  
 
Substances and chemicals 
Stock solutions of the pharmacological substances amiloride, mibefradil, nifedipine (Sigma), 
PcTx1 (a generous gift from Michel Lazdunski), APETx2 (Smartox, Saint Martin d'Hères, 
France), Mambalgin-1 (Peptides International, Louisville, USA) and ω-conotoxin MVIIC 
(Latoxan, Valence, France) were made in water, including 0.3% BSA for the toxins. The 
stock solution of BCTC (Enzo Life Sciences, Lausen, Switzerland) was made in DMSO. 
Solutions containing the peptides PcTx1 or ω-conotoxin MVIIC were pre-applied for 60s and 
then again included in the acidic solution. Mambalgin-1 was pre-applied for 30s but not 
included in the stimulation solution (Diochot et al., 2012). Mambalgin-1 was tested prior to 
the CGRP secretion experiments in patch-clamp experiments with human ASIC1a and rat 
ASIC1b (Suppl. Fig. S1), showing a substantial (~55%) current inhibition and IC50 values 
that were close to the published values (Diochot et al., 2012). The observed inhibition of 
ASIC1a is different from the findings of Diochot and colleagues, who had measured a 
maximally ~80% inhibition of ASIC1a, in contrast to 57 ± 2% in our hands. ASIC1b 
inhibition by mambalgin-1 was very similar in their study. The observed difference may be 
due to the different ortholog or the stimulation pH (rat ASIC1a at pH 5.5 in (Diochot et al., 
2012), human ASIC1a at pH 6 in the present study). However, these experiments showed that 
the synthetic mambalgin-1 inhibited at 100 nM ≥ 50% of the pH 6-induced ASIC1 activity.  
 
CGRP secretion assay 
Neurons in coated 24-well plates were used ~18h after plating. They were washed with PBS, 
followed by a washing step with PBS containing protease inhibitors (Leupeptin (1µg/ml), 
Pepstatin (1µg/ml), Aprotinin (1µg/ml), PMSF (1 mM) (Roche, Rotkreuz, Switzerland) and 
0.3 % bovine serum albumin (BSA, protease free, Acros Organics). Protease inhibitors and 
0.3 % BSA were included in all solutions used in this assay. Secretion was measured during a 
15-min period at 37°C in Tyrode of the same composition as used in the imaging experiments, 
whose pH had been adjusted to the desired value and which contained pharmacological 
inhibitors as indicated. It was preceded by a pre-incubation period of 5 min with control or 
drug-containing Tyrode. The Ca2+-free Tyrode solution contained, in mM, 140 NaCl, 4 KCl, 
2MgCl2, 10 MES, 10 Hepes, 10 glucose, 2 EGTA. The KCl Tyrode solution contained, in 
mM, 70 NaCl, 74 KCl, 2 CaCl2, 1 MgCl2, 10 MES, 10 HEPES, 10 Glucose. After the 
incubation, the supernatant of each well was transferred into a polyethylene tube (Nunc-
Immuno™ Tubes MiniSorp, Fisher Scientific, Wohlen, Switzerland) and kept on ice. Tubes 
were centrifuged for 10 min at 500 rpm at 4°C. The supernatants were transferred into new 
polyethylene tubes and then frozen at -80 °C. The cells of each well were incubated for 5 min 
with 100 µl lysis buffer (150 mM NaCl, 50 mM Tris pH 7.5, 5 mM EDTA, 1% Triton X-100), 
then harvested. The lysates were transferred to polyethylene tubes, sonicated at 4°C and 
frozen at -80 °C. They were used to determine the cellular content of CGRP in order to 
normalize the secretion of each well. The CGRP content of the supernatants and the lysate 
samples was measured using a rat CGRP enzyme immunoassay kit (SPI-bio, Montigny le 
Bretonneux, France) according to the manufacturer’s recommendations, with the following 
modifications. The CGRP standard serial dilutions were made in Tyrode, pH 7.4, containing 
protease inhibitors and 0.3 % BSA. An additional incubation step (O/N, 4°C) was performed 





Results are presented as mean ± SEM. A t-test was used for experiments including < 3 
groups, and comparison of different groups, if >2 groups were involved, was done by one-
way ANOVA followed by Tukey post-hoc test.  P < 0.05 was considered significant. 
 
Results 
ASIC subunits are preferentially expressed in the peptidergic population of small diameter 
DRG neurons 
We analyzed first whether ASICs and TRPV1 were co-expressed with the neuropeptides 
CGRP or SP in acutely dissociated adult rat DRG neurons. ASIC subunits were visualized 
with specific antisense probes, while TRPV1, CGRP, SP and the neuronal marker NeuN were 
detected by specific antibodies (see Materials and methods). Figure 1A illustrates the double 
labeling of ASIC1a and CGRP. For in situ raw data of other ASICs see Suppl. Fig. S2. The 
presence of NeuN was used to identify neurons. Based on such experiments, the percentage of 
neurons expressing the channel isoform or the neuropeptide, both or none of them was 
determined. These experiments were done with neurons of soma diameter ≤ 30 µm. CGRP 
and SP were detected in approximately 60 % of the neurons (Fig. 1B). ASIC1a mRNA was 
present in about 60% of small diameter DRG neurons and was co-expressed with CGRP 
peptide in 43%, and with SP peptide in 49% of small diameter neurons, indicating a large 
overlap in the expression of ASIC1a and of the neuropeptides (Fig. 1B). ASIC3 mRNA was 
present in ~50% of the small-diameter neurons. Its degree of co-expression with the 
neuropeptides was slightly lower than that of ASIC1a. ASIC1b, ASIC2a and ASIC2b were 
detected in 35-40% of small-diameter neurons. These ASIC subtypes were almost exclusively 
present in neuropeptide-positive neurons. As a consequence of the lower expression 
frequency of these ASIC subtypes, approximately 50% of the neuropeptide-positive neurons 
did not express the ASIC (Fig. 1B). ASIC and also TRPV1 expression was then analyzed by 
immunocytochemistry. These experiments were carried out on the total population of DRG 
neurons. TRPV1 was present in about half of the neurons, and was preferentially co-expressed 
with the neuropeptides (Fig. 1B). The available, tested antibodies for ASIC1 and ASIC2 do 
not distinguish between splice variants (Gannon et al., 2008; Wemmie et al., 2003).  ASIC1 
(thus including both splice variants, ASIC1a and ASIC1b) was present in about 50% of the 
neurons, and was mostly co-expressed with CGRP or SP (Suppl. Figs. S3A-B). ASIC2 was 
present in ~40% of the neurons; ~80 % of ASIC2-expressing neurons also expressed the 
neuropeptides, while ~35% of neuropeptide-expressing neurons were ASIC2-negative (Suppl. 
Fig. S3C), confirming the observations with in situ hybridization. In summary, the expression 
of TRPV1, ASIC1a and ASIC3 in DRG neurons is highly correlated with that of 
neuropeptides.  
 
Heterologously expressed ASIC1a and TRPV1 mediate acidification-induced Ca2+ entry  
In a first set of functional experiments on recombinant channels we confirmed with Ca2+ 
imaging that under our experimental conditions both TRPV1 and ASIC1a allow Ca2+ entry, 
and we determined the concentration dependence of their inhibitors for later use (Suppl. Fig. 
S4A-D). Extracellular acidification induced an increase in intracellular Ca2+ concentration in 
TRPV1- and in ASIC1a-expressing CHO cells. The ASIC inhibitor amiloride and the TRPV1 
inhibitor BCTC (4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-
piperazinecarboxamide) required concentrations of  500 and 5 µM, respectively, to inhibit 
90% of the acidification-induced Ca2+ increase.  
To determine the Ca2+ permeability of ASIC1a, the current-voltage relationship of pH 6-
induced currents of ASIC1a was recorded by whole-cell patch-clamp in an extracellular 
solution that contained as permeant ion either Na+ or Ca2+ (Suppl. Fig. S4E). From the shift of 
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the current-voltage relationship the Na+/Ca2+ permeability ratio  was calculated as 11.3 ± 2.0 
(n=5). In contrast, TRPV1 has a ~10-fold preference for Ca2+ with a Na+/Ca2+  permeability 
ratio  of ~0.1 (Caterina et al., 1997).  
 
Amiloride prevents the acid-induced Ca2+ entry in a population of DRG neurons 
The pharmacological inhibitors were used to determine the relative contribution of TRPV1 
and ASICs to acid-induced Ca2+ entry in DRG neurons. We classified neurons in Ca2+ 
imaging experiments as partially amiloride-sensitive when 30-70%, and as amiloride-sensitive 
when >70% of the fluorescence increase at pH 6 was prevented by 500 µM amiloride. The 
population of amiloride-sensitive neurons, expressing thus almost exclusively ASICs as pH 
sensors (Fig. 2A & E), comprised 53% of the neurons (Fig. 3E). Twelve percent of the 
neurons were partially amiloride-sensitive. In these cells, ASICs contribute a part of the Ca2+ 
entry. In 35% of the neurons (Fig. 3E) the pH 5- and pH 6-induced Ca2+ entry was not 
inhibited by 500 µM amiloride (Fig. 2B). In this population amiloride did not affect the 
amplitude at pH 6, and induced an increase in fluorescence at pH 5, which was however not 
statistically significant (Fig. 2B & E). Comparison of the relative amplitudes in the absence of 
amiloride shows that in the amiloride-sensitive and partially -sensitive populations there was 
no increase in amplitude between pH 6 and pH 5, indicating that pH 6 already fully activated 
Ca2+ entry in these cells. This is consistent with the pH dependence of ASICs. In the 
amiloride-resistant population, there was a ~40% increase in current amplitude between pH 6 
and pH 5, likely reflecting the pH dependence of TRPV1, which requires more acidic pH than 
ASICs for activation. The fluorescence signal was transient in amiloride-sensitive neurons, 
returning to basal levels during the extracellular perfusion with the acidic solution. This 
desensitization was much less pronounced in amiloride-resistant neurons, as shown by the 
higher ratio between the fluorescence amplitude 20 s after the beginning of the pH 5 
stimulation and the peak amplitude (Suppl. Fig. S5, p<0.01), consistent with the presence of 
TRPV1, which does not desensitize (Tominaga et al., 1998). BCTC (5 µM) substantially 
inhibited the Ca2+ entry in half of the amiloride-resistant neurons, indicating that TRPV1 
contributed importantly to the Ca2+ entry in these neurons (Figs. 2D, 2F and 3E). In 
amiloride-resistant neurons the desensitization kinetics of the BCTC-resistant Ca2+ signal 
were faster than those of BCTC-sensitive signals. The amplitude at 20s /peak amplitude ratio 
was at pH 6 0.93 ± 0.04 and 0.60 ± 0.10 (n=4) for the amiloride-resistant BCTC-sensitive and 
the amiloride- and BCTC-resistant signal, respectively. The nature of the amiloride- and 
BCTC-resistant Ca2+ entry way is not clear. It is however known that K+ channels, especially 
some two-pore domain K+ channels that are also expressed in DRG neurons are inhibited by 
acidification (Enyedi and Czirjak, 2010; Medhurst et al., 2001). This inhibition would 
therefore lead to membrane depolarization and possibly to Ca2+ entry. 
 
Psalmotoxin 1 identifies neurons expressing Ca2+-permeable ASICs 
Psalmotoxin 1 (PcTx1) inhibits homomeric ASIC1a channels at nanomolar concentrations 
and does not inhibit ASICs formed by other subunits, nor ASIC1a-containing heteromers, 
with the exception of ASIC1a/2b (Escoubas et al., 2000; Sherwood et al., 2011). PcTx1 is 
therefore selective for the Ca2+-permeable ASIC isoforms. It was used as a tool to determine 
the proportion of amiloride-sensitive neurons expressing Ca2+-permeable ASICs.  Ten nM 
PcTx1 inhibited > 70% of the pH 6-induced increase of the intracellular Ca2+ concentration in 
64% of the amiloride-sensitive neurons, indicating that in these neurons the Ca2+ entry was 
mediated by ASIC1a or ASIC1a/2b (Fig. 3A & D, n=9). This PcTx1-sensitive sub-population 
accounted for ~30% of the total number of DRG neurons.  In the remaining 36% of amiloride-
sensitive neurons PcTx1 was ineffective in inhibiting the response to pH 6 (Figs. 3B & D), 
indicating that in these neurons the Ca2+ entry was induced by activation of ASICs other than 
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ASIC1a and ASIC1a/2b. This result is comparable with a previous study showing that the 
PcTx1-sensitive current was present in about half of the ASIC-expressing neurons (Poirot et 
al., 2006). PcTx1 had no effect on amiloride-resistant Ca2+ entry (Fig. 3C-D).   
Together, the functional experiments indicate the presence of the following neuron 
populations with regard to acid-induced Ca2+ entry, as illustrated in Fig. 3E. In 53% of the 
neurons ASICs exclusively mediate acid-induced Ca2+ entry, in 12% both ASICs and TRPV1 
contribute to it, and in the remaining 35%, TRPV1 and other entry ways but no ASICs are 
involved. Two thirds of the neurons with exclusive ASIC-mediated Ca2+ entry are PcTx1-
sensitive, expressing therefore ASIC1a homotrimers or ASIC1a/2b heterotrimers.    
 
Inhibitors of voltage-gated Ca2+ channels reduce the amplitude of ASIC-mediated Ca2+ 
increase in DRG neurons 
TRPV1 as well as ASIC1a and ASIC1a/2b are Ca2+-permeable and can therefore mediate 
directly the entry of Ca2+ when they are activated. The other ASICs and possibly in part also 
the Ca2+-permeable ASICs may allow Ca2+ entry indirectly by membrane depolarization due 
to their Na+ inward current, thereby activating Cavs. To determine the contribution of Cavs, 
the Cav inhibitors Nifedipine (10 µM), Mibefradil (10 µM) and ω-conotoxin MVIIC (300 nM) 
were used together. Figure 4A illustrates a typical experiment of an amiloride-sensitive 
neuron, whose pH 6-induced Ca2+ entry was strongly decreased by the Cav inhibitors. In 
amiloride-resistant neurons the Cav inhibitors did not affect Ca2+ entry (Fig. 4B-C). Assuming 
that the Ca2+ entry is mediated in many of these neurons by TRPV1 that has a high Ca2+ 
permeability, less inhibition by the Cav blockers would indeed be expected than in amiloride-
sensitive neurons.  
As another way of testing a direct Ca2+ entry versus one mediated by depolarization-activated 
Cavs, Na+ in the extracellular solution was replaced by the ASIC-impermeant ion N-
methylglucosamine to remove the component of the ASIC-mediated depolarization that is due 
to Na+ entry.  To measure the Ca2+ entry via ASICs that are known to display some Ca2+ 
permeability (Sherwood et al., 2011; Waldmann et al., 1997), these experiments were carried 
out on PcTx1-sensitive neurons. The absence of extracellular Na+ reduced the fluorescence 
increase by ~4-fold (Fig. 4D-E), indicating that approximately 25% of the Ca2+ entry occurred 
directly via the ASIC1a or ASIC1a/2b pore.   
 
TRPV1 activation induces CGRP secretion from DRG neurons 
To test whether activation of ASICs or TRPV1 leads to neuropeptide secretion, the CGRP 
concentration in the supernatant of DRG neurons was measured after a 15-min exposure to 
different pH conditions. The ratio of secreted CGRP/total cellular CGRP content was 
determined in each secretion experiment, and this ratio, normalized to the corresponding 
value for the pH 7.4 control condition, is presented in Fig. 5. Extracellular acidification to pH 
6 or 5, but not to 6.5 increased the neuronal secretion of CGRP compared to the basal level at 
pH 7.4 (Fig. 5A). In the absence of extracellular Ca2+, acidification to pH 6 did not increase 
CGRP secretion (Fig. 5B), confirming that neuropeptide secretion from DRG neurons 
depends largely on Ca2+ entry. Since we have shown in functional experiments that the 
depolarization due to Na+ influx plays an important role in the ASIC-mediated Ca2+ entry 
(Fig. 4E) we also tested whether the absence of Na+ would affect the pH 6-induced CGRP 
secretion. This was however not the case (Fig. 5B). Amiloride could not be used as ASIC 
inhibitor in these experiments, since at 500 µM it had a tendency of increasing the CGRP 
release (data not shown). This increase might be caused by non-specific effects of amiloride 
during the incubation period that is longer than in Ca2+ imaging experiments. In the longer 
time frame used for these experiments, inhibition of the Na+/H+ exchanger or other 
transporters by amiloride may have ASIC-independent effects on cell function and survival 
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(Masereel et al., 2003). Alternatively, the recently discovered activation of sustained ASIC3 
currents by amiloride (Li et al., 2011; Yagi et al., 2006) might be at the origin of the increased 
CGRP secretion in the presence of amiloride. This is however less likely, since amiloride 
activates ASICs only at pH more alkaline than pH 6.5 and we observed the increased CGRP 
secretion at pH 6 and pH 5 (data not shown). Amiloride had also shown a tendency of 
increasing Ca2+ entry in a population of neurons (Fig. 2B &E). To replace amiloride as ASIC 
inhibitor we used a combination of peptide toxins. APETx2 inhibits ASIC3 and ASIC3-
containing heteromers as well as some voltage-gated Na+ channels (Blanchard et al., 2012; 
Diochot et al., 2003; Peigneur et al., 2012). Mambalgin-1 inhibits ASIC1a, ASIC1b and 
ASIC1a-containing heteromers (Diochot et al., 2012). The combination of APETx2 and 
Mambalgin-1 (each at 1 µM) inhibits most of the DRG ASIC currents at pH 6, since ASIC2a 
and ASIC2a-containing heteromers that do not contain ASIC1a or ASIC3 activate at more 
acidic pH). The combination of these toxins did however not prevent pH 6-induced CGRP 
secretion (Fig. 5C). Individual application of these toxins or of PcTx1 did not affect CGRP 
secretion, excluding a role of the Ca2+-permeable or non-permeable ASICs. In contrast, the 
TRPV1 inhibitor BCTC (1 µM) significantly reduced the CGRP secretion at pH 6 and 5 (Fig. 
5D, p<0.05), indicating that TRPV1 is the major sensor involved in acidification-induced 
CGRP release from DRG neurons. This was further confirmed by the observation that the 
combination of Cav inhibitors did not affect pH 6-induced CGRP secretion (Fig. 5E). Cavs 
contribute to Ca2+ entry induced by ASIC activation as shown in Fig. 4, but are certainly less 
important for Ca2+ entry mediated by the highly Ca2+-permeable TRPV1. The Cav inhibitors 
prevented most of the Ca2+ entry induced by KCl depolarization, indicating that activation of 
the DRG Cavs can induce neuropeptide secretion, as shown previously in many studies 
(Huang and Neher, 1996). The KCl-induced depolarization is sustained in contrast to the 
transient ASIC-induced depolarization.   
 
Discussion  
Extracellular acidification induces depolarization and neuropeptide release from DRG 
neurons. We show that in DRG neurons, TRPV1, ASIC1a and ASIC3 are preferentially co-
expressed with the neuropeptides CGRP and SP. The acid-induced Ca2+ entry was mediated 
by ASICs or TRPV1, or both of them together. Acid-induced CGRP secretion depended on 
extracellular Ca2+. Its pH dependence and pharmacological profile indicate a sensor role for 
TRPV1 but not ASICs in this process.  
 
Sub-populations of DRG neurons  
Our in situ hybridization / immunocytochemistry approaches indicate that the two 
neuropeptides CGRP and SP are present in ~60% of small-diameter DRG neurons and that 
they are co-expressed in 35-40% of the neurons with TRPV1, ASIC1a or ASIC3. Co-
expression of these channels with the neuropeptide is therefore found in 70-100% of 
neuropeptide-positive neurons. Less correlation with neuropeptide expression was observed 
for ASIC1b, ASIC2a and ASIC2b. The Ca2+ imaging experiments showed that DRG neurons 
express either functional ASICs or TRPV1, and in a small population of neurons both of 
them. In approximately 30% of the neurons the PcTx1-sensitive ASIC1a and/or ASIC1a/2b 
are the exclusive pH sensors.  
In most studies investigating co-expression of H+-activated channels and neuropeptides in 
DRG neurons, the channels were identified by functional analysis. One study measured 
capsaicin-induced currents in ~60 % and ASIC-like currents in 40% of small-diameter rat 
DRG neurons (Petruska et al., 2000). We have previously found ASIC currents in ~60 % of 
small-diameter rat DRG neurons, which were in many neurons co-expressed with TRPV1 
(Poirot et al., 2006).  In a proportion of these neurons, TRPV1 and the ASICs produced only 
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small current amplitudes and would probably not be detected by Ca2+ imaging or in situ 
hybridization that are less sensitive than patch-clamp. Several studies on rat and mouse DRG 
neurons showed a preferential ASIC expression in IB4-negative neurons (Dirajlal et al., 2003; 
Liu et al., 2004; Poirot et al., 2006). In mouse, IB4-negative DRG neurons express almost 
exclusively neuropeptides, while this negative correlation is much weaker in rat (Barabas et 
al., 2012; Price and Flores, 2007). 
PcTx1-sensitive currents were found only in 5% of rat DRG neurons in one study (Deval et 
al., 2008), and in ~30% of DRG neurons in our previous study (Poirot et al., 2006). Recently 
it was shown that PcTx1 inhibits not only ASIC1a homotrimers as initially thought, but also 
ASIC1a/2b heterotrimeric channels (Sherwood et al., 2011). The same study also showed that 
zinc exerts a stronger inhibition on ASIC1a than on ASIC1a/2b. In DRG neurons a strong 
inhibition by zinc of PcTx1-sensitive currents was observed (Poirot et al., 2006), suggesting 
that a substantial proportion of the PcTx1-sensitive DRG neurons express ASIC1a 
homotrimers. One study analyzed the expression of TRPV1 and of individual ASIC subunits 
by in situ hybridization in rat DRG sections (Ugawa et al., 2005). In the cited study, ASIC1a 
and ASIC1b were mostly detected in distinct neurons, and were in a small percentage of 
neurons co-expressed with other ASIC subunits. ASIC subunits were expressed in 10-35% of 
neurons, thus at a lower frequency than in other studies. TRPV1 was present in ~40% of 
neurons, and in many of them together with ASIC1a or ASIC3. In conclusion, although our in 
situ hybridization analysis rather suggests a high degree of co-expression of different ASIC 
subunits within single neurons, it is consistent with the possible existence of a sub-population 
of neurons expressing a high proportion of ASIC1a homotrimers, identified with PcTx1 in the 
Ca2+ imaging experiments and in previous functional studies.  
 
Pathway of acid-induced Ca2+ entry into DRG neurons 
TRPV1 has a high Ca2+ permeability, whereas most ASICs are Ca2+-impermeable and only 
ASIC1a and ASIC1a/2b are to some extent Ca2+ permeable (Bassler et al., 2001; Sherwood et 
al., 2011; Sutherland et al., 2001; Waldmann et al., 1997). Therefore it is expected that ASICs 
allow Ca2+ entry in part by direct Ca2+ conductance and in part by depolarization-induced 
activation of Cavs. Several studies demonstrated the Ca2+ permeability of recombinant 
ASIC1a, however the estimates of the Na+ /Ca2+ permeability ratio varied between 1.8 and 
18.5 (Bassler et al., 2001; Sherwood et al., 2011; Sutherland et al., 2001; Waldmann et al., 
1997; Yermolaieva et al., 2004).  Thus, there is solid evidence for a Ca2+ permeability of  the 
recombinant ASIC1a in spite of a recent study that challenged these findings by proposing the 
Ca2+ entry through ASIC1a channels to be negligible (Samways et al., 2009). In Ca2+ imaging 
with neurons, a clear distinction between the direct and the indirect ASIC-mediated Ca2+ 
would require pharmacological blockade of Cavs, or ion substitution and has not been 
reported so far. A study measuring simultaneously ASIC currents and increases in 
intracellular Ca2+ concentrations in DRG neurons found Ca2+ increases that closely matched 
the ASIC current kinetics, but could not completely exclude an indirect Ca2+ entry (Jiang et 
al., 2006). By measuring the current-voltage relationship of ASIC currents in PC12 cells, a 
Ca2+ permeability was demonstrated (Chu et al., 2002).  We show here, by using Cav 
inhibitors and ion substitution experiments that the ASIC-mediated Ca2+ influx in DRG 
neurons is largely Cav-dependent. Even in neurons whose H+-induced Ca2+ influx was 
inhibited by PcTx1 and thus mediated by Ca2+-permeable ASICs, only ~25% of the Ca2+ 
influx occurred directly via the ASICs. The high Ca2+ permeability of TRPV1 is well 
documented, and further confirmed by our observation that Cav inhibitors did not affect Ca2+ 





Calcium entry via TRPV1, but not ASICs induces CGRP secretion 
We show that acidification induces CGRP secretion that largely depends on the presence of 
extracellular Ca2+, indicating that Ca2+-independent secretion mechanisms account at most for 
a small proportion of CGRP secretion. We observed CGRP release from DRG neurons by 
acidification to pH 5 and 6, but not pH 6.5. Many ASIC subtypes display substantial activity 
at pH 6.5, while the pH dependence of TRPV1 is shifted by approximately one pH unit to 
more acidic values. The pH dependence and the pharmacological profile of the CGRP release 
showed that TRPV1, but not ASICs mediate the acid-induced CGRP secretion. As mentioned 
in the introduction, TRPV1-mediated neuropeptide secretion has been shown in several 
studies from different tissues (Fischer et al., 2003; Kichko and Reeh, 2009; Strecker et al., 
2005). Given the clear evidence for co-expression of ASICs and neuropeptides, and ASIC-
mediated Ca2+ entry, what are the possible reasons for the incapacity of ASICs to induce 
neuropeptide secretion?  Close sub-cellular co-localization may be required for linking the 
Ca2+ entry to the neuropeptide release, and this may be different between ASICs/Cavs and  
TRPV1. We show that Cav activation by KCl-induced depolarization induces CGRP 
secretion. Electrical stimulation was shown to induce neuropeptide secretion via Cav 
activation in skin-nerve preparations, indicating together that Cavs are well positioned for this 
purpose (Kress et al., 1999). In the cited study the electrical stimulation was strong and lasted 
for several min. Likely, the Ca2+ entry needs to be sufficiently intense and long lasting to 
induce neuropeptide secretion. Although we did not determine the absolute intracellular Ca2+ 
concentrations reached in Ca2+ imaging experiments, the comparison of the amplitude of 
fluorescence changes mediated by amiloride-sensitive and -resistant pathways showed no 
obvious difference between these two groups. We observed however with ASIC-mediated 
Ca2+ entry after the peak a fast decline in intracellular Ca2+ concentration that was not 
observed in amiloride-resistant cells. It is likely that during a sustained acidification the 
ASIC-mediated Ca2+ entry may be limited by the channel desensitization.     
In conclusion, we have examined the contribution of TRPV1 and of ASICs to acid-induced 
neuropeptide secretion from DRG neurons. While we confirm a role of TRPV1 in this 
process, we show that ASICs, although co-expressed with neuropeptides and capable of 
mediating Ca2+ entry do not induce CGRP secretion. 
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Figure Legends 
Fig. 1.  Preferential co-expression of TRPV1, ASIC1a and ASIC3 with neuropeptides in 
small diameter DRG neurons. A. Analysis of ASIC1a and CGRP expression in DRG 
neurons. Shown is anti-NeuN antibody staining (purple), ASIC1a antisense probe staining 
(green), and anti-CGRP antibody staining (red), and a merge of ASIC1a and CGRP staining; 
scale bar, 100 µm. B. Pie charts showing the proportion of neurons expressing ASIC1a, -1b, -
2a, -2b, -3 or TRPV1 and either CGRP or SP, in DRG neurons. ASIC expression (green) was 
determined by in situ hybridization, neuropeptide (CGRP in red, SP in red with white dots) 
and TRPV1 expression (blue) by immunocytochemistry. Labeling of 58-357 neurons from 1-
4 animals was measured per analysis type.  
 
Fig. 2. Amiloride inhibits the acid-induced Ca2+ entry in a population of DRG neurons. 
Ca2+ imaging from DRG neurons. A-D. Representative experiments from an amiloride-
sensitive neuron (A), an amiloride-resistant neuron (B), an amiloride- and BCTC-resistant 
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neuron (C) and an amiloride-resistant, BCTC-sensitive neuron (D). Note that C and D are 
shown on a different time scale and that the last pH 6 application is longer than the previous 
applications. E. Summary of experiments with amiloride (500 µM), the F340/380 ratio is 
normalized to this ratio at pH 5 control, n = 4-5 for each group. Neurons were classified as 
“partially amiloride-sensitive” if amiloride prevented 30-70% of the increase in intracellular 
Ca2+ concentration, and  “amiloride-sensitive” if inhibition was > 70%.  F. Effect of 5 µM 
BCTC on pH 6-induced Ca2+ entry in amiloride-resistant neurons, n=4 for each group. For C 
and D, *, p < 0.05, **, p<0.01 compared to the respective condition without inhibitor 
(ANOVA, followed by Tukey post-hoc test). 
 
Fig. 3. PcTx1 inhibits Ca2+-permeable ASICs in a sub-population of amiloride-sensitive 
neurons. Ca2+ imaging from DRG neurons. Representative experimental traces of pH 6-
induced intracellular Ca2+ concentration increase are shown for A, a neuron inhibited by 
amiloride and PcTx1, B, a neuron inhibited by amiloride but not PcTx1 and C, a neuron 
resistant to both inhibitors. D, Summary of PcTx1 experiments. The F340/380 ratio is 
normalized to that of the pH 6 control, n = 5-9 for each group; inhibitor concentrations were 
500 µM amiloride and 10 nM PcTx1.  PcTx1 was pre-applied for 1 min and co-applied with 
the pH 6 solution. *, p < 0.05 and, **, p < 0.01 compared to pH 6 control in direct comparison 
(paired ANOVA and Tukey post-hoc test). The F340/380 ratio in the presence of PcTx1 was 
different between the three groups, and the F340/380 ratio in the presence of amiloride was 
different between the amiloride-sensitive and –resistant groups (ANOVA and Tukey post-hoc 
test, p<0.05, not indicated in the figure). E, Pie chart summarizing the proportions of the 
different populations and sub-populations of neurons, based on the functional experiments 
(Figs. 2 and 3, n=42).  
 
Fig. 4. Opening of voltage-gated Ca2+ channels is involved in ASIC-mediated Ca2+ entry. 
Representative experimental traces of pH 6-induced intracellular Ca2+ concentration increase 
are shown for A, an amiloride-sensitive neuron partially inhibited by the combination of Cav 
inhibitors Nifedipine (10 µM), Mibefradil (10 µM) and ω-conotoxin MVIIC (300 nM) and B, 
an amiloride-resistant neuron whose Ca2+ entry was not affected by the Cav inhibitors. C, 
Summary of the data with Cav inhibitors. The F340/380 ratio is normalized to the pH 6 control, 
n=10. D, Representative experiment and E, summary of experiments with pH 6-induced Ca2+ 
entry in PcTx1-sensitive (10 nM) neurons with normal and Na+-free Tyrode solution, n=3-4. 
PcTx1 was pre-applied for 1 min and co-applied with the pH 6 solution. For C and E, *, 
p<0.05 and ***, p<0.001, compared to control pH 6-induced Ca2+ entry (Paired ANOVA and 
Tukey post-hoc test). 
 
Fig. 5. Extracellular acidification promotes CGRP secretion from DRG neurons via the 
activation of TRPV1. Secretion was measured for 15 min at 37°C. The amount of secreted 
CGRP is expressed as % of the total CGRP content of the cells, normalized to the condition at 
pH 7.4. A, pH dependence of CGRP secretion. B, Dependence on the presence of 
extracellular Ca2+ or Na+.  C, Effect of ASIC antagonists. The concentrations used for the 
experiments were 10 nM PcTx1, 1µM mambalgin-1, 1µM APETx2. D, Effect of 1 µM 
BCTC. E, Effect of Cav inhibitors; nifedipine (10 µM), mibefradil (10 µM) and ω-conotoxin 
MVIIC (300 nM) were used together.F, depolarization-induced CGRP secretion by 70 mM 
KCl (pH 7.4). All drugs were pre-applied for 5 min and were co-applied during the secretion 
experiment; n = 7-28 (A), n = 4-6 (B), n = 3-9 (C), n = 6-12 (D), n = 4-12 (E), n = 6-7 (F). *, 
**, ***, different from pH 7.4 control, p < 0.05, p < 0.01 and p < 0.001, respectively; #, 
different from the corresponding control condition at the same pH (p < 0.05); one-way 
ANOVA followed by Tukey post-hoc test, carried out before normalization to pH 7.4 control. 
anti NeuN antibody anti CGRP antibody
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1.2 pH 6 + amiloride
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Figure 4, Boillat et al.
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